Your browser doesn't support javascript.
loading
High Numbers of Circulating CD57+ NK Cells Associate with Resistance to HER2-Specific Therapeutic Antibodies in HER2+ Primary Breast Cancer.
Muntasell, Aura; Servitja, Sònia; Cabo, Mariona; Bermejo, Begoña; Pérez-Buira, Sandra; Rojo, Federico; Costa-García, Marcel; Arpí, Oriol; Moraru, Manuela; Serrano, Laia; Tusquets, Ignasi; Martínez, María Teresa; Heredia, Gemma; Vera, Andrea; Martínez-García, María; Soria, Laura; Comerma, Laura; Santana-Hernández, Sara; Eroles, Pilar; Rovira, Ana; Vilches, Carlos; Lluch, Ana; Albanell, Joan; López-Botet, Miguel.
Afiliação
  • Muntasell A; Immunity and Infection, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain. amuntasell@imim.es jalbanell@hospitaldelmar.cat.
  • Servitja S; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Cabo M; Department of Medical Oncology, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Bermejo B; Immunity and Infection, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Pérez-Buira S; Department of Oncology, Hospital Clinico de Valencia-CIBERONC, Valencia, Spain.
  • Rojo F; Department of Pathology, IIS "Fundacion Jimenez Diaz University Hospital," Madrid, Spain.
  • Costa-García M; Department of Pathology, IIS "Fundacion Jimenez Diaz University Hospital," Madrid, Spain.
  • Arpí O; Universitat Pompeu Fabra, Barcelona, Spain.
  • Moraru M; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Serrano L; HLA-Immunogenetics Department, Instituto Hospital Universitario Puerta de Hierro, Majadahonda, Spain.
  • Tusquets I; Department of Pathology, Hospital del Mar, Barcelona, Spain.
  • Martínez MT; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Heredia G; Department of Medical Oncology, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Vera A; Universitat Pompeu Fabra, Barcelona, Spain.
  • Martínez-García M; Department of Oncology, Hospital Clinico de Valencia-CIBERONC, Valencia, Spain.
  • Soria L; Universitat Pompeu Fabra, Barcelona, Spain.
  • Comerma L; Immunity and Infection, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Santana-Hernández S; Cancer Research Program, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Eroles P; Department of Medical Oncology, Hospital del Mar-CIBERONC, Barcelona, Spain.
  • Rovira A; Immunity and Infection, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Vilches C; Department of Pathology, Hospital del Mar, Barcelona, Spain.
  • Lluch A; Immunity and Infection, IMIM (Institut Hospital del Mar d'Investigacions Mèdiques), Barcelona, Spain.
  • Albanell J; Department of Oncology, Hospital Clinico de Valencia-CIBERONC, Valencia, Spain.
  • López-Botet M; Biomedical Research Institute, INCLIVA, Valencia, Spain.
Cancer Immunol Res ; 7(8): 1280-1292, 2019 08.
Article em En | MEDLINE | ID: mdl-31189644
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Matadoras Naturais / Contagem de Linfócitos / Resistencia a Medicamentos Antineoplásicos / Antígenos CD57 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias da Mama / Células Matadoras Naturais / Contagem de Linfócitos / Resistencia a Medicamentos Antineoplásicos / Antígenos CD57 / Antineoplásicos Imunológicos Tipo de estudo: Prognostic_studies / Risk_factors_studies Limite: Adult / Aged / Female / Humans / Middle aged Idioma: En Revista: Cancer Immunol Res Ano de publicação: 2019 Tipo de documento: Article